SequelSEC

Streamex Corp. STEX

Electromedical & Electrotherapeutic Apparatus · CIK 0001530766 · Fiscal year ends 1231

Revenue
$40.00K
Fiscal year ended 2024-12-31
Operating income
-$12.86M
Fiscal year ended 2024-12-31
Free cash flow
Unavailable
Fiscal year ended 2024-12-31

Streamex Corp. (STEX) reported revenue of $40.00K and net income of -$10.33M for the fiscal year ended 2024-12-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Streamex Corp.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.

Income

Streamex Corp. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-31
Revenue$40.00K
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$12.86M
Net income-$10.33M
Research & development$832.00K
Weighted-average diluted sharesUnavailable
Pretax income-$10.34M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$11.63M
Selling & marketingUnavailable

Balance

Streamex Corp. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-31
Cash & equivalentsUnavailable
Total assets$842.00K
Current assets$388.00K
Total liabilities$2.26M
Current liabilities$2.26M
Total equity incl. NCI-$1.53M
Temporary (mezzanine) equity$105.00K
InventoryUnavailable
Accounts receivable$109.00K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Streamex Corp. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-31
Operating cash flow-$4.76M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$4.71M
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$188.00K

Derived

Streamex Corp. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-31
Free cash flowUnavailable
Gross marginUnavailable
Operating margin-32155.0%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.17x
Revenue YoY growth122.2%
Net margin-25825.0%
R&D / revenue2080.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open STEX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-15View SEC filing
10-Q · Filed 2025-05-19View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.